How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
What if every person you meet, including those you’ve yet to cross paths with, is quietly tethered to you by a single thread you can't even see? That's the premise of the invisible string theory. The ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
A reverse mortgage allows homeowners to cash in on the value they've poured into their homes. Unlike home equity loans or HELOCs, however, they don't have to make payments until they move out or pass ...
The co-founders of startup Ricursive Intelligence seemed destined to be co-founders. Anna Goldie, CEO, and Azalia Mirhoseini, CTO, are so well-known in the AI community that they were among those AI ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Isabel Casimiro, MD, PhD, is an endocrinologist at the University of Chicago in Illinois. As a physician-scientist in molecular biology, she uses her research on diabetes, lipid disorders, ...
One skate trick. One video. One big problem. When Misha lands a trick at the skatepark, her friends film it on their phones. It’s meant to be fun… until an edited version of the video suddenly appears ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results